SciTransfer
Organization

INTEL CORPORATION

Global semiconductor leader providing HPC hardware, AI acceleration, and cloud computing expertise to EU research consortia.

Large industrial companydigitalBENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€508K
Unique partners
22
What they do

Their core work

Intel Corporation is one of the world's leading semiconductor and computing technology companies, designing and manufacturing processors, accelerators, FPGAs, and related hardware that power everything from data centers to edge devices. In the EU research context, Intel's Belgian entity participates as an industry partner bringing hardware and software co-design expertise, particularly in high-performance computing and computer vision. Their H2020 contributions span exascale computing for scientific applications and cloud-based video analytics, reflecting Intel's strategic interest in validating its hardware platforms within EU-funded research at scale. As an industry heavyweight in any consortium, Intel typically provides access to cutting-edge silicon, developer tools, and deep expertise in parallel computing architectures.

Core expertise

What they specialise in

High-Performance Computing and Exascale Architecturesprimary
1 project

ExCAPE (2015–2018) targeted exascale compound activity prediction, where Intel's role almost certainly involved HPC hardware platforms and parallel computing frameworks.

Cloud Computing and Video Analyticsprimary
1 project

Cloud-LSVA (2016–2018) focused on large-scale cloud video analysis, an area where Intel contributes hardware acceleration, OpenVINO-type inference, and cloud-optimised processor stacks.

AI and Machine Learning Hardware Accelerationsecondary
2 projects

Both projects — predictive modelling at exascale and large-scale video inference — sit squarely in domains where Intel develops dedicated AI acceleration silicon and software toolchains.

Drug Discovery and Scientific Computingsecondary
1 project

ExCAPE's objective of predicting compound biological activity using exascale compute places Intel at the intersection of pharmaceutical HPC and computational chemistry.

Evolution & trajectory

How they've shifted over time

Early focus
Exascale HPC and drug discovery
Recent focus
Cloud video analytics and AI inference

Intel's two H2020 projects both ran between 2015 and 2018, making it impossible to identify a genuine keyword shift across time — the entire EU research footprint falls within the same early period. Within that window, the projects reveal a dual focus: scientific computing at extreme scale (ExCAPE) and cloud-driven media intelligence (Cloud-LSVA), which mirrors Intel's broader strategic pivot during that era from pure CPU performance toward AI inference and data-centric workloads. Beyond 2018, Intel has no recorded H2020 participation in this dataset, which may indicate a shift to Horizon Europe, direct investment channels, or internal R&D rather than public project consortia.

Intel's trajectory in these projects points toward AI-accelerated workloads at scale — a direction fully consistent with their subsequent product investments in Gaudi AI accelerators and OpenVINO, making them a natural industry anchor for future Horizon Europe projects in AI hardware, edge inference, or scientific computing.

Collaboration profile

How they like to work

Role: specialist_contributorReach: Global12 countries collaborated

Intel operates exclusively as a consortium participant rather than a coordinator, consistent with how large technology companies typically engage in EU research — contributing platform expertise and validating technology in real-world research settings without carrying the administrative burden of project leadership. With 22 unique partners across 12 countries from just two projects, Intel brings wide network diversity per project rather than a pattern of repeated partnerships. Working with Intel in a consortium signals hardware credibility and access to advanced computing infrastructure, but expectations should be calibrated accordingly: they are a high-value specialist contributor, not a project driver.

Intel's Belgian entity has collaborated with 22 distinct organisations across 12 countries through only two projects, indicating participation in large, geographically diverse consortia rather than tight bilateral relationships. The 12-country spread suggests strong pan-European reach, consistent with Intel's role as a pan-European industry anchor in research consortia.

Why partner with them

What sets them apart

Intel is one of the few private-sector partners in H2020 that brings both the hardware platform and the software ecosystem — silicon, compilers, and optimised libraries — making them uniquely able to close the gap between research prototypes and production-ready deployable systems. For any consortium working on compute-intensive workloads (HPC, AI inference, large-scale data processing), Intel's participation adds both technical credibility and a clear path-to-market via commercially available technology. However, given their very limited H2020 footprint in this dataset, partners should confirm which Intel division or research lab is actually engaged, as the Belgian legal entity may act as the formal participant while technical work is distributed globally.

Notable projects

Highlights from their portfolio

  • ExCAPE
    The only project with recorded EC funding (EUR 507,500), ExCAPE tackled exascale computing for pharmaceutical compound activity prediction — an ambitious convergence of HPC hardware and drug discovery that positioned Intel at the frontier of scientific AI before the term became mainstream.
  • Cloud-LSVA
    Cloud-LSVA applied large-scale cloud infrastructure to video analysis, placing Intel in the emerging computer vision and media analytics space at a time when video AI was transitioning from research to industrial deployment.
Cross-sector capabilities
health and pharmaceutical research computingmanufacturing quality control via computer visionscientific data infrastructure and HPCsecurity and surveillance analytics
Analysis note: Only 2 projects with no keyword metadata; one project has no recorded EC funding. The profile relies heavily on domain knowledge of Intel as a company rather than evidence from project data alone. The Belgian legal entity (Kontich) may be a holding or administrative unit — the actual research contributions likely come from Intel Labs or specific product divisions. Any prospective partner should verify which Intel team would be involved before pursuing collaboration based on this profile.